
Top asthma medicines sold worldwide 2018, by revenue
In 2018, the top asthma medicine sold worldwide based on revenue was Seretide/Advair by GlaxoSmithKline, generating some 3.22 billion U.S. dollars. British company GlaxoSmithKline is the leading manufacturer of global top asthma products with five out of the top 10 products.